IS3S:XETRA:XETRA-iShares Edge MSCI World Value Factor UCITS ETF USD (Acc) EUR (EUR)

ETF | Others |

Last Closing

USD 37.355

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+1.44 (+3.51%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+2.41 (+2.75%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.76 (+3.64%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.46 (+3.89%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.17 (+3.51%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.72 (+3.50%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.31 (+2.76%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.63 (-1.14%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.31 (+3.36%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.30 (+0.25%)

USD 12.26B

ETFs Containing IS3S:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.02% 48% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.02% 50% F 48% F
Trailing 12 Months  
Capital Gain -5.86% 33% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.86% 36% F 39% F
Trailing 5 Years  
Capital Gain 62.20% 69% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.20% 70% C- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 13.57% 78% C+ 77% C+
Dividend Return 13.57% 77% C+ 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.54% 54% F 63% D
Risk Adjusted Return 117.59% 96% N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike